DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for DENV replicon assay are 10




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_6132Ribavirin Nucleobase
NA
NA
Dengue virus
New Guinea C
Pathway
DENV replicon assay
Decrease (50 %)
NA
29672522
DrugRepV_6133Mizoribine Nucleobase
NA
NA
Dengue virus
New Guinea C
Pathway
DENV replicon assay
Decrease (50 %)
NA
29672522
DrugRepV_6134T-1105
NA
Zika virus
Dengue virus
New Guinea C
Pathway
DENV replicon assay
Decrease (50 %)
NA
29672522
DrugRepV_6135Diaminopurine
NA
NA
Dengue virus
New Guinea C
Pathway
DENV replicon assay
Decrease (50 %)
NA
29672522
DrugRepV_6136Favipiravir
Antiviral
Influenza virus
Dengue virus
New Guinea C
Pathway
DENV replicon assay
Decrease (50 %)
Investigational
29672522
DrugRepV_6137Mycophenolic Acid
Antineoplastic and Immunomodulating Agents
Organ rejection (immunosuppressants)
Dengue virus
New Guinea C
Pathway
DENV replicon assay
Decrease (50 %)
Approved
29672522
DrugRepV_6138Ribavirin
Antiinfectives For Systemic Use
Hepatitis C virus
Dengue virus
New Guinea C
Pathway
DENV replicon assay
Decrease (50 %)
Approved
29672522
DrugRepV_6139Mizoribine
Immunosuppressant
Rheumatoid Arthritis
Dengue virus
New Guinea C
Pathway
DENV replicon assay
Decrease (50 %)
Investigational
29672522
DrugRepV_6140T-1106
NA
Yellow Fever virus
Dengue virus
New Guinea C
Pathway
DENV replicon assay
Decrease (50 %)
NA
29672522
DrugRepV_6141Diaminopurine Riboside
NA
NA
Dengue virus
New Guinea C
Pathway
DENV replicon assay
Decrease (50 %)
NA
29672522